Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathway

Cancer Science

Volumn 100, Issue 8, 2009, Pages 1460-1467

  Sasazawa, Yukiko ^a   Futamura, Yushi ^a   Tashiro, Etsu ^a   Imoto, Masaya ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; APOPTOSIS INDUCING FACTOR; BAFILOMYCIN A1; CAMPTOTHECIN; CASPASE; CONCANAMYCIN B; CYTOCHROME C; DESTRUXIN E; ENDONUCLEASE G; HYDROLASE INHIBITOR; INOSTAMYCIN; PACLITAXEL; PROTEIN BCL XL; UNCLASSIFIED DRUG; VACUOLAR ADENOSINE TRIPHOSPHATASE INHIBITOR; VINBLASTINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-X PROTEIN; CASPASES; CELL LINE, TUMOR; CYTOCHROME C GROUP; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; ENDODEOXYRIBONUCLEASES; ENZYME INHIBITORS; HUMANS; LUNG NEOPLASMS; MACROLIDES; MEMBRANE POTENTIAL, MITOCHONDRIAL; PACLITAXEL; SMALL CELL LUNG CARCINOMA; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 67650654677     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01194.x     Document Type: Article

References (40)

1. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899-911.
2. Boise LH, Gonzalez-Garcia M, Postema CE et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608.
3. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in.vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
4. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17: 3878-85.
5. Kim R. Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochem Biophys Res Commun 2005; 333: 336-43.
6. Susin SA, Lorenzo HK, Zamzami N et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-6.
7. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412: 95-9.
8. Widlak P, Li LY, Wang X, Garrard WT. Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J Biol Chem 2001; 276: 48 404-9.
9. Yang J, Liu X, Bhalla K et al. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
10. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-3.
11. Wang S, Yang D, Lippman ME. Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists. Semin Oncol 2003; 30: 133-42.
12. Wang JL, Liu D, Zhang ZJ et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci USA 2000; 97: 7124-9.
13. Oltersdorf T, Elmore SW, Shoemaker AR et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435: 677-81.
14. Kitada S, Leone M, Sareth S, Zhai D, Reed JC, Pellecchia M. Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 2003; 46: 4259-64.
15. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997; 387: 773-6.
16. Kawatani M, Imoto M. Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashion. J Biol Chem 2003;278: 19 732-42.
17. Futamura Y, Sawa R, Umezawa Y et al. Discovery of incednine as a potent modulator of the anti-apoptotic function of Bcl-xL from microbial origin. J Am Chem Soc 2008; 130: 1822-3.
18. Imoto M, Umezawa K, Takahashi Y et al. Isolation and structure determination of inostamycin, a novel inhibitor of phosphatidylinositol turnover. J Nat Prod 1990; 53: 825-9.
19. Yoshimoto Y, Imoto M. Induction of EGF-dependent apoptosis by vacuolar-type H(+)-ATPase inhibitors in A431 cells overexpressing the EGF receptor. Exp Cell Res 2002; 279: 118-27.
20. Tzung SP, Kim KM, Basanez G et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol 2001; 3: 183-91.
21. Takemoto Y, Watanabe H, Uchida K et al. Chemistry and biology of moverastins, inhibitors of cancer cell migration, produced by Aspergillus. Chem Biol 2005; 12: 1337-47.
22. Tsuchiya A, Tashiro E, Yoshida M, Imoto M. Involvement of nuclear accumulation of heat shock protein 27 in leptomycin B-induced apoptosis in HeLa cells. J Antibiotics 2005; 58: 810-16.
23. Païs M, Das BC, Ferron P. Depsipeptides from Metarhizium anisopliae. Phytochemistry 1981; 20: 715-23.
24. + -ATPases. Trends Biochem Sci 1989; 14: 113-16.
25. Kinashi H, Someno K, Sakaguchi K. Isolation and characterization of concanamycins A, B and C. The J Antibiotics 1984; 37: 1333-43.
26. + -ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 1991; 266: 17 707-12.
27. Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 2006; 57: 545-53.
28. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-84.
29. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998; 391: 96-9.
30. + -ATPase. J Biol Chem 1997; 272: 4795-803.
31. +-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002; 3: 94-103.
32. + -ATPase in cancer biology. Cell Biochem Biophys 2004; 40: 185-206.
33. De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 2005; 1: 779-86.
34. Lu X, Qin W, Li J et al. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res 2005; 65: 6843-9.
35. Tafani M, Cohn JA, Karpinich NO, Rothman RJ, Russo MA, Farber JL. Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-alpha. J Biol Chem 2002; 277: 49 569-76.
36. Hu Y, Benedict MA, Wu D, Inohara N, Nunez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 1998; 95: 4386-91.
37. Ravagnan L, Gurbuxani S, Susin SA et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001; 3: 839-43.
38. Kalinowska M, Garncarz W, Pietrowska M, Garrard WT, Widlak P. Regulation of the human apoptotic DNase/RNase endonuclease G: Involvement of Hsp70 and ATP. Apoptosis 2005; 10: 821-30.
39. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000; 97: 7871-6.
40. Chinnathambi S, Tomanek-Chalkley A, Bickenbach JR. HSP70 and EndoG modulate cell death by heat in human skin keratinocytes in.vitro. Cells Tissues Organs 2008; 187: 131-40.